Document:

Exhibit 10.2

 

PLEDGE AGREEMENT

 

THIS PLEDGE AGREEMENT (“Agreement”),
dated as of October , 2016 between Amarantus Biosciences Holdings, Inc. ("Borrower") by and among (a) Xpress Group International
Limited (“Xpress”), Dominick Membership, LLC ("Dominick") and together with Xpress,
"Purchasers" and each, a "Purchaser") for the benefit of Purchasers referred to
below (it being understood that subject to the terms of the Purchase Agreement (as defined below), any right, remedy, privilege
or power of Purchasers shall be exercised by each Purchaser together or individually.

 

RECITALS

 

WHEREAS, pursuant to that certain Securities
Purchase Agreement dated as of even date herewith, by and among the a) the Purchasers on the one hand, and (b) Borrower, on the
other hand (including all annexes, exhibits and schedules thereto, as from time to time amended, restated, supplemented or otherwise
modified, the "Purchase Agreement"), the Borrower has agreed to sell to Purchasers, and Purchasers have
agreed to purchase, the Notes upon the terms and subject to the conditions set forth therein; and

 

WHEREAS, it is a condition precedent to the obligation
of Purchasers to purchase the Notes that the Borrower shall have executed and delivered this Agreement (as defined herein) to secure
payment and performance of the Obligations.

 

WHEREAS, as a partial inducement to the Purchasers
to enter into the Purchase Agreement, Borrower has agreed to provide security for payment of the Obligations.

 

NOW, THEREFORE, in consideration of the premises
and the covenants set forth herein and in the Loan Agreement, the parties hereto agree as follows:

 

1.           Pledge. In order to secure the payment
and performance in full of all of the Note, Borrower hereby pledges, assigns, grants a security interest in, transfers and delivers
unto the Purchaser all of Borrower’s right, title and interest in and to 5.5 million restricted shares of Avant Diagnostics,
Inc. common stock owned by the Borrower. (the “Pledged Stock” or the “Collateral”), together with all other
rights appurtenant to the Pledged Stock (excluding voting rights which shall be maintained by the Borrower), as well as all cash
and non-cash proceeds of any and all of the foregoing. The Borrower shall cause to have issued within 5 days of closing, certificates
totaling 5.5 million shares of the Pledged Stock in pro-rata proportion to each Purchaser's investment amount.

 

2.           Custody. Until payment in full of
the Note, the Purchasers will hold physical possession of the certificates representing the Pledged Common Stock and will not sell
transfer or otherwise dispose of the stock other than as contemplated in the Purchase Agreement.

 

      

     

    

 

3.           Representations and Warranties.
Borrower hereby agrees that each delivery of Pledged Common Stock shall constitute a representation and warranty to the Purchasers
that as of the date thereof:

 

(a)         Borrower is the sole
holder of record and beneficial owner of the Pledged Common Stock free and clear of any pledge, hypothecation, assignment,
lien, charge, claim, security interest, option, preference, priority or other preferential arrangement of any kind or nature
whatsoever ("Lien") thereon or affecting the title thereto, other than security interest granted to certain secured
creditors (the “Secured Investors”) of the Borrower (herein represented by the Delafield Investments, the
“Collateral Agent”), all of whom agree to release the Pledged Stock to the Purchaser in the event of an event of
default as defined in the Purchase Agreement. .

 

(b)         The Pledged Common Stock has
been duly authorized and validly issued by each of the respective issuers and are fully paid and non-assessable, and Borrower has
the right and all requisite authority to pledge, assign, grant a security interest in, transfer and deliver the Collateral to the
Purchaser as provided herein.

 

(c)         This Agreement has been duly
authorized, executed and delivered by Borrower and constitutes the legal, valid and binding obligation of Borrower, enforceable
in accordance with its terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors' rights generally
and subject, as to enforceability, to general principles of equity.

 

(d)         No consent, approval, authorization
or other order of any person or entity other than the approval of the Collateral Agent pursuant to the inter-creditor agreement
(“Original ICA”) dated as of April 14, 2016, as amended with the inter-creditor agreement executed concurrently with
the Purchase Agreement (“First Amended ICA”) with approval having been evidenced, is required for (i) the execution
and delivery of this Agreement by Borrower or the delivery by Borrower of the Collateral to the Purchaser as provided herein except
as may be required in connection with the disposition of the Collateral by laws affecting the offering and sale of securities generally.

 

(e)         Upon the delivery to the Purchaser
of the certificates representing the Pledged Common Stock, the Purchaser will have a valid and perfected security interest therein
subject to no prior Lien.

 

(f)         
There are no rights, options, warrants or privileges outstanding with respect to the Pledged Common Stock.

 

The representations and warranties set forth
in this Section 3 shall survive the execution and delivery of this Agreement.

 

    2

     

    

 

4.           Rights of Borrower. Unless an Event
of Default under the Purchase Agreement shall have occurred and be continuing:

 

(a)         Borrower shall be entitled to
exercise any and all voting and other consensual rights pertaining to the Pledged Stock or any part thereof for any purpose not
inconsistent with the terms of this Agreement or the Loan Agreement; provided, that Borrower shall not exercise or refrain
from exercising such right if, in the Purchaser's judgment, such action would have a material adverse effect on the value of the
Pledged Common Stock or any part thereof, and provided, further, that Borrower shall give the Purchaser at least
five days' prior written notice of the manner in which he intends to exercise, or the reasons for refraining from exercising, any
such right.

 

(b)         All dividends and all other distributions
in respect of any of the Collateral, whenever paid or made, shall be delivered to the Purchaser and held by it subject to the lien
created by this Agreement.

 

5.           Covenants. Borrower covenants and
agrees that until the termination of this Agreement:

 

(a)         Borrower
will not, without the prior written consent of the Purchaser, sell, assign, transfer, mortgage, pledge or otherwise encumber
any of its rights in or to the Collateral or any dividends or other distributions or payments with respect thereto or grant a
Lien on any thereof.

 

(b)         Borrower will, at its own expense,
execute, acknowledge and deliver all such instruments and take all such action as the Purchaser from time to time may reasonably
request in order to ensure to the Purchaser the benefits of the first priority Lien on and to the Collateral intended to be created
by this Agreement.

 

(c)         Borrower will defend the title
to the Collateral and the Lien of the Purchaser thereon against the claim of any person or entity claiming against or through Borrower
and will maintain and preserve such Lien so long as this Agreement shall remain in effect.

 

6.           Remedies.

 

(a)         Upon the occurrence of an Event
of Default under the Note, then or at any time during the continuance of such occurrence, the Purchaser is hereby authorized and
empowered, at its election, to exercise any and all rights and remedies hereunder, under any other security agreement securing
the Note or otherwise available under law, in any order or simultaneously, including, but not limited to, the right (i) to exercise
all voting rights with respect to the Pledged Stock, (ii) to demand, sue for, collect, receive and give acquittance for any and
all cash dividends or other distributions or monies due or to become due upon or by virtue thereof, and to settle, prosecute or
defend any action or proceeding with respect thereto, (iii) to sell in one or more sales the whole or any part of the Collateral,
subject to any legal restrictions, or otherwise to transfer or assign the same, applying the proceeds therefrom to the payment
of the Obligations in such order as the Purchaser shall determine, and otherwise act with respect to the Collateral as if the Purchaser
were the outright owner thereof, Borrower hereby irrevocably constituting the Purchaser as its proxy and attorney-in-fact, with
full power of substitution to do so.

 

    3

     

    

 

(b)         Borrower agrees that it will
not at any time use any law now or hereafter in force in order to prevent or delay the enforcement of this Agreement, or the absolute
sale of the whole or part of the Collateral or the possession thereof by any purchaser at any sale hereunder, and Borrower waives
the benefit of all such laws to the extent it lawfully may do so. Borrower agrees that it will not interfere with any right, power
and remedy of the Purchaser provided for in this Agreement or now or hereafter existing at law or in equity or by statute or otherwise,
or the exercise or beginning of the exercise by the Purchaser of any one or more such rights, powers or remedies. No failure or
delay on the part of the Purchaser to exercise any such right, power or remedy, and no notice or demand which may be given to or
made upon Borrower by the Purchaser with respect to any such remedies, shall operate as a waiver thereof, or limit or impair the
Purchaser's right to take any action or to exercise any power or remedy hereunder without notice or demand, or prejudice its rights
as against Borrower in any respect.

 

7.           Exoneration of the Purchaser. Other
than the exercise of reasonable care in the custody and preservation of the Collateral, the Purchaser shall have no duty with respect
thereto. The Purchaser shall be deemed to have exercised reasonable care in the custody and preservation of the Collateral in its
possession if the Collateral is accorded treatment substantially equal to that which it accords its own property, and shall not
be liable or responsible for any loss or damage to any of the Collateral, or for any diminution in the value thereof, by reason
of the act or omission of any agent or bailee selected by the Purchaser in good faith.

 

8.           Waiver. No delay on the Purchaser's
part in exercising any power of sale or other right hereunder, and no notice or demand which may be given to or made upon Borrower
by the Purchaser with respect to any power of sale or other right hereunder, shall constitute a waiver thereof, or limit or impair
the Purchaser's right to take any action or to exercise any power of sale or any other right hereunder, without notice or demand,
or prejudice the Purchaser's rights as against Borrower in any respect.

 

9.           Assignment. Neither party may assign
its rights under this Agreement, except that in the event of assignment by the Purchaser of its rights under the Loan Agreement
in accordance therewith, the party to whom such assignment is made shall be entitled to the Purchaser's rights hereunder.

 

    4

     

    

 

10.         Termination. At such time as (a)
the amounts owed by the Borrower to the Purchaser shall have been fully satisfied pursuant to the Purchase Agreement, the Purchaser
shall deliver to Borrower the Collateral at the time subject to this Agreement and all instruments of assignment executed in connection
therewith, free and clear of the lien hereof and all of Borrower's obligations hereunder shall thereupon terminate. When so released,
such Collateral shall be free and clear of any lien or encumbrance hereunder or under the Purchase Agreement.

 

11.         Expenses. Borrower will reimburse
the Purchaser for all expenses (including reasonable expenses for legal services of every kind) of, or incidental to the preparation
or enforcement of any of the provisions of, this Agreement or any actual or attempted sale, or any exchange, enforcement, collection,
compromise or settlement of any of the Collateral and for the care of the Collateral and defending or asserting the rights and
claims of the Purchaser in respect of the Collateral, by litigation or otherwise, including, but not limited to, expenses of insurance
and the fees and expenses of counsel for the Purchaser. All such expenses shall be deemed additional Obligations.

 

12.         Miscellaneous.

 

(a)         The Purchaser may execute any of its duties
hereunder by or through agents or employees. The Purchaser may consult with legal counsel and any action taken or suffered in good
faith in accordance with the advise of such counsel shall be full justification and protection to it.

 

(b)         Neither the Purchaser nor any of its officers,
directors, employees, agents or counsel shall be liable for any action lawfully taken or omitted to be taken by it or them hereunder
or in connection herewith, except for their own gross negligence or willful misconduct and the Purchaser shall not be liable for
any error of judgment made by it in good faith.

 

(c)         This Agreement shall be binding upon Borrower
and its successors and assigns, and shall inure to the benefit of, and be enforceable by, the Purchaser and its successors, transferees
and assigns. None of the terms or provisions of this Agreement may be waived, altered, modified or amended except in writing duly
signed for and on behalf of the Purchaser and Borrower.

 

(d)         THIS
AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO
CONTRACTS MADE AND PERFORMED IN SUCH STATE.

 

    5

     

    

 

13.         Further Assurances; the Purchaser May
Perform.

 

(a)         At Borrower's expense, Borrower will do
all such acts, and will furnish to the Purchaser all such financing statements, certificates, legal opinions and other documents
and will do or cause to be done all such other things as the Purchaser may reasonably request from time to time in order to give
full effect to this Agreement and to secure the rights intended to be granted to the Purchaser hereunder. To the extent permitted
by applicable law, Borrower hereby authorizes the Purchaser to execute and file, in the name of Borrower or otherwise, Uniform
Commercial Code financing statements (which may be photocopies of this Agreement) which the Purchaser in its sole discretion may
deem necessary or appropriate.

 

(b)         If Borrower fails to perform any act required
by this Agreement, the Purchaser may perform, or cause performance of, such act, and the expenses of the Purchaser incurred in
connection therewith shall be governed by Section 11 hereof.

 

14.         Severability. Any provision of
this Agreement which is prohibited or unenforceable in any jurisdiction shall not invalidate the remaining provisions hereof, and
any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any
other jurisdiction.

 

IN WITNESS WHEREOF, the parties hereto have caused
this Pledge Agreement to be duly executed as of the date first above written.

 

[The rest of the page left
intentionally blank]

 

    6

     

    

  

DELAFIELD INVESTMENTS LIMITED, as Collateral
Agent

 

	By:	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:	 	 

  

XPRESS GROUP INTERNATIONAL LIMITED

 

	By:	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:	 	 

 

DOMINICK MEMBERSHIP, LLC

 

	By:	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:	 	 

 

AMARANTUS BIOSCIENCE HOLDINGS, INC.

 

	By:	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:	 	 

 

 

7Exhibit 10.3

 

First
Amendment to Intercreditor and Subordination Agreement

 

This FIRST AMENDMENT TO INTERCREDITOR
AND SUBORDINATION AGREEMENT (“First Amendment”), dated as of October [___], 2016, by and among the holders
of the Company’s Series E Preferred Stock (the “Series E Holders”) and the holders of the Company’s
Series H Preferred Stock (“Series H Holders”), Amarantus Bioscience
Holdings, Inc. (the “Company”), all of the subsidiaries of the Company (such subsidiaries, the “Subsidiaries”,
the Company jointly and severally, together with their respective successors and
assigns, collectively, the “Debtors”), GEMG LLC (“GEMG”), ANSON INVESTMENTS MASTER FUND
LP (“Anson”), DOMINION CAPITAL, LLC, (“Dominion”) and DELAFIELD INVESTMENTS LIMITED (“Delafield”)
the holders (collectively, the “April 2016 Holders”) of the Company’s 12% OID Senior Secured Convertible
Promissory Notes, in the original aggregate principal amount of $4,000,000 pursuant to the Senior Loan Agreement, Delafield
in its capacity as collateral agent (in such capacity, the “Collateral Agent”) and Dominick Membership
LLC and Xpress Group International Limited.

 

W I T N E S S E T H:

 

WHEREAS, Series E Holders,
Series H Holders, the Debtors, GEMG, Anson, Dominion, Delafield, the April 2016 Holders and Delafield, in its capacity as collateral
agent, are party to that certain Intercreditor and Subordination Agreement dated as of April 14, 2016 (the “April 2016
Intercreditor Agreement”);

 

WHEREAS, the Company desires
to obtain new financing from Xpress Group International Limited (“Xpress”) and Dominick Membership LLC (“Dominick”;
together with Xpress, collectively, the “October 2016 Holders”) in the aggregate principal amount of $250,000,
on the terms set forth in that certain Securities Purchase Agreement dated as of October [___] 2016 by and among the Company and
the October 2016 Holders, which financing shall be secured by shares owned by the Company in Avant Diagnostics, Inc. (the “Avant
Common Stock”) pursuant to a Pledge Agreement dated October [___] 2016;

 

WHEREAS, the parties to the
April 2016 Intercreditor Agreement wish to amend the April 2016 Inercreditor Agreement to, among other things, add the October
2016 Lenders as parties to the April 2016 Intercreditor Agreement;

 

NOW, THEREFORE, in consideration
of the mutual agreements, provisions and covenants contained herein, the parties agree as follows:

 

1.           Definitions.
Capitalized terms not otherwise defined herein shall have them meaning ascribed to them in the April 2016 Intercreditor Agreement.

 

    	 	1	 

     

    

 

2.           Amendments.
The following specific provisions of the April 2016 Intercreditor Agreement are hereby amended as follows:

 

(a)          The
definition of “Senior Loan Agreement” is hereby deleted and restated as follows:

 

“Senior Loan Agreement”
means the Securities Purchase Agreement dated as of July 9, 2015 among the Company, and GEMG, as the same may be amended,
modified or supplemented from time to time, including, without limitation, amendments, modifications, supplements and restatements
thereof giving effect to increases, renewals, extensions, refundings, deferrals, restructurings, replacements or refinancings
of, or additions to, the arrangements provided in such Loan Agreement (whether provided by GEMG or a successor thereto
or other lenders).

 

(b)         The
definition of “Subordinated Lenders” is hereby amended to include Dominick, Xpress, Dominion, Anson and Delafield,
in addition to the Series H Holders.

 

(c)         The
definition of “Senior Lenders” is hereby amended to remove Anson, Dominion and Delafield. For the avoidance of doubt,
after giving effect to this First Amendment, the only Senior Lender shall be GEMG.

 

(d)         Section
4(e) of the April 2016 Intercreditor Agreement is deleted and restated as follows:

 

(e) Any money,
property or securities realized upon the sale, disposition or other realization by the Senior Lender upon all or any part of the
Collateral, shall be applied by the Senior Lender in the following order:

 

(i)         First,
to the payment in full of all costs and expenses (including, without limitation, attorneys’ fees and disbursements) paid
or incurred by the Senior Lender in connection with the such realization on the Collateral or the protection of their rights and
interests therein;

 

(ii)         Second,
to the payment in full of all Senior Obligations in such order as the Senior Lender may elect in its sole discretion;

 

(iii)        Third,
, to the payment in full of the notes issued pursuant to the October SPA;

 

(iv)        Fourth,
to the payment in full of all Subordinated Obligations in such order as the Subordinated Lenders may elect in its sole discretion
which are secured by such Collateral, which shall be paid to the Subordinated Lenders; and

 

(vi)        Fifth,
to pay to the Debtors, or its representative or as a court of competent jurisdiction may direct, any surplus then remaining.

 

    	 	2	 

     

    

 

(e)       Schedule
I attached to the April 2016 Intercreditor Agreement is hereby deleted entirely replaced with the “Amended Schedule I”
attached to this First Amendment.1

 

3.           Amendments
in Writing; No Waiver; Cumulative Remedies..

 

(a)         None
of the terms or provisions of this First Amendment may be waived, amended, supplemented or otherwise modified except by a written
instrument executed by the Senior Lender, the Debtors and each of the Subordinated Lenders; provided that any provision of this
First Amendment may be waived by the Senior Lender in a letter or agreement executed by the Senior Lender or by telex or facsimile
transmission from the Senior Lender.

 

(b)         No
failure to exercise, nor any delay in exercising, on the part of either the Senior Lender or the Subordinated Lenders, any right,
power or privilege hereunder shall operate as a waiver thereof. No single or partial exercise of any right, power or privilege
hereunder shall preclude any other or further exercise thereof or the exercise of any other right, power or privilege.

 

(c)         The
rights and remedies herein provided are cumulative, may be exercised singly or concurrently and are not exclusive of any other
rights or remedies provided by law.

 

4.           Counterparts.
This First Amendment may be executed in any number of counterparts, but all of such counterparts shall together constitute
but one and the same agreement. In making proof of this First Amendment, it shall not be necessary to produce or account for more
than one counterpart thereof signed by each of the parties hereto. Delivery of an executed counterpart of this First Amendment
by telecopier or other electronic means shall have the same force and effect as delivery of an original executed counterpart of
this First Amendment. Any party delivering an executed counterpart of this First Amendment by telecopier or other electronic means
also shall deliver an original executed counterpart of this First Amendment, but the failure to deliver an original executed counterpart
shall not affect the validity, enforceability, and binding effect of this First Amendment as to such party or any other party.

 

5.           Successors
and Assigns.

 

(a)         This
First Amendment shall be binding upon the successors, heirs, administrators, executors and assigns of the Debtors and the Subordinated
Lenders and shall inure to the benefit of the Senior Lender and their successors and assigns.

 

 

1 NTD: Lenders to complete
updated schedule, which calls for listing the Subordinated Debt Documents.

 

    	 	3	 

     

    

 

(b)         Upon
a successor Senior Lender becoming the Senior Lender under the Senior Loan Agreement, such successor Senior Lender automatically
shall become the Senior Lender hereunder with all the rights and powers of the Senior Lender hereunder without the need for any
further action on the part of any party hereto.

 

6.           Severability.
Any provision of this First Amendment which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and
any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any
other jurisdiction.

 

7.           Integration.
This First Amendment represents the agreement of the Senior Lender and the Subordinated Lenders with respect to the subject
matter hereof and there are no promises or representations by the Senior Lender or the Subordinated Lenders relative to the subject
matter hereof not reflected herein.

 

[SIGNATURE PAGE FOLLOWS]

 

    	 	4	 

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this First Amendment to be duly executed and delivered as of the day and year first above written.

 

SENIOR LENDERS:

 

GEMG LLC

 

	By:	       	 
	 	 	 
	Title:	 	 

Amount of Preferred Stock:______

Amount of Debt:______________

  

[SIGNATURE PAGES OF THE SUBORDINATED
LENDERS AND DEBTORS FOLLOW]

 

Signature Page to First Amendment
to Intercreditor and Subordination Agreement

 

     

     

    

 

[SIGNATURE PAGES OF THE SUBORDINATED LENDERS]

 

HOLDERS OF SERIES E PREFERRED STOCK:

 

DOMINION CAPITAL, LLC

 

	By:	       	 
	 	 	 
	Title:	 	 

Amount of Preferred Stock:______

Amount of Equity:_____________

 

[________________________]

  

	By:	       	 
	 	 	 
	Title:	 	 

Amount of Preferred Stock:______

Amount of Equity:_____________

 

[________________________]

 

	By:	       	 
	 	 	 
	Title:	 	 

Amount of Preferred Stock:______

Amount of Equity:_____________

 

HOLDERS OF SERIES H PREFERRED STOCK:

 

ANSON INVESTMENTS MASTER FUND LP

 

	By:	       	 
	 	 	 
	Title:	 	 

Amount of Preferred Stock:______

Amount of Equity:_____________

 

[________________________]

 

	By:	       	 
	 	 	 
	Title:	 	 

Amount of Preferred Stock:______

Amount of Equity:_____________

 

Signature Page to First Amendment
to Intercreditor and Subordination Agreement

 

     

     

    

 

[SIGNATURE PAGES OF THE SUBORDINATED LENDERS, CONT’D]

 

ANSON INVESTMENTS MASTER FUND LP

 

	By:	       	 
	 	 	 
	Title:	 	 

Amount of Preferred Stock:______

Amount of Debt:______________

 

DELAFIELD INVESTMENTS LIMITED, on behalf of itself and as Collateral
Agent

 

	By:	       	 
	 	 	 
	Title:	 	 

Amount of Preferred Stock:______

Amount of Debt:______________

Amount of Equity:_____________

 

DOMINION CAPITAL, LLC

 

	By:	       	 
	 	 	 
	Title:	 	 

Amount of Preferred Stock:______

Amount of Debt:______________

Amount of Equity:____________

 

[SIGNATURE PAGES OF THE DEBTORS
FOLLOW]

 

Signature Page to First Amendment
to Intercreditor and Subordination Agreement

 

     

     

    

 

DEBTORS:

 

	AMARANTUS BIOSCIENCE HOLDINGS, INC.	 
	 	 	 
	By:	              	 
	Name:	 	 
	Title:	 	 
	 	 	 
	AMARANTUS THERAPEUTICS, INC.	 
	 	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 
	 	 	 
	AMARANTUS THERAPEUTICS, INC.	 
	 	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 
	 	 	 
	AMARANTUS MA, INC.	 
	 	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 
	 	 	 
	CUTANOGEN CORPORATION	 
	 	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 

 

Signature Page to First Amendment
to Intercreditor and Subordination Agreement

 

     

     

    

 

AMENDED SCHEDULE I

 

[TO BE COMPLETED]

 

 

Signature Page to First Amendment
to Intercreditor and Subordination Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}]]